The 1 November 2014 issue of the Schedule of Pharmaceutical Benefits is now available and in effect. The new issue contains a number of new and revised listings:

• Amino acid formula with vitamins and minerals without valine, leucine and isoleucine (MSUD amino5) - new formulation
• Glucose indicator (Contour Next) - new formulation
• Indacaterol maleate with glycopyrronium bromide (Ultibro Breezhaler) - new combination product
• Perampanel hemisesquihydrate (Fycompa) - new medicine
• Triglycerides - medium chain (Peptamen Junior) - new formulation
• Vitamins, minerals and trace elements with carbohydrate (FruitVits) - new formulation
• Botulinum toxin type A (Botox) - new indication
• Paclitaxel (nanoparticle albumin bound) (Abraxane) - new indication

For more details, go to: http://www.pbs.gov.au/browse/publications